The Antibody Society has partnered with numerous conference organizers, including Informa Connect, Cambridge Healthtech Institute, Hanson Wade and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
11th Open Scientific Symposium of the European Immunogenicity Platform
February 17-19, 2020, Lisbon, Portugal
The European Immunogenicity Platform acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the area of immunogenicity. The yearly Open Scientific Symposium brings together experts from industry, academy and regulatory agencies. The meeting consists of 3 days of presentations, panel discussions, including an optional one-day Introduction to Immunogenicity course.
The 11th Open Symposium of the EIP will highlight current hot topics in the immunogenicity area. As a participant, you will learn about immunogenicity of novel gene therapies, multi-domain biologics, regulatory expectations, innovative ADA assay approaches and latest achievements in respect to prediction of an ADA response. Our organizing committee succeeded in attracting high class speakers from academia, leading biopharmaceutical companies/CROs and regulatory authorities. A dedicated workshop day and a panel discussion will provide you with a plenty of opportunities to directly address your questions to experts in the field. Registration to our scientific conference also includes an invitation to our famous local social evening event with great additional occasions for networking.
The Festival of Biologics San Diego 2020
March 2-4, 2020
Loews Resort Colonardo, San Diego
The Festival of Biologics is the meeting place for the life science community to bridge the gap between academia and industry.
With three events in one, we encourage conversation so you can inspire change, champion innovation, and address complex challenges that the biologics industry is facing. Together, we’re improving patient health.
Society members save 15% on the registration fee! Contact us at firstname.lastname@example.org for the code.
Americas Antibody Congress
- Erica Ollmann Saphire, Professor, La Jolla Institute for Immunology
- Bruce Keyt, CSO, IGM Biosciences
- Philip Tagari, VP. Therapeutic Discovery, Amgen
- David Dornan, Senior Vice President of Research, Bolt Biotherapeutics
- Joan Shen, CEO, I-Mab Biopharma
World Immunotherapy Congress
- Andrew Allen, President and Chief Executive Officer, Gritstone Oncology
- Bob Valamehr, Vice President of Cancer Immunotherapy, Fate Therapeutics
- Ira Mellman, Vice President, Cancer Immunology, Genentech
- William Chou, Vice President, Global Commercial Disease Leader, Novartis
- Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer,
- Merck Sharp & Dohme
World Biosimilar Congress
- Christine Simmon, Executive Director/Senior Vice President, Policy & Strategic Alliances, Biosimilars Council/Association of Accessible Medicines
- John O’Brien, Former Senior Adviser to the Secretary for Drug Pricing Reform, U.S. Department of Health and Human Services
- Noelle Sunstrom, CEO & Founder, NeuClone
- Pam Traxel, Senior Vice President, Alliance Development and Philanthropy, American Cancer Society Cancer Action Network
- Scott Liu, CEO, Shanghai Henlius
World ADC London
March 2-5, 2019, London
Celebrating its 10th year, World ADC is returning to London bigger and better than ever. Covering the A to Z of ADCs, World ADC London will continue to curate and distill the field’s latest scientific advances and lessons learned, particularly from the last 12 months. Join the likes of AstraZeneca, Sanofi and Bayer at this definitive forum to maximise the therapeutic index of your ADC pipeline.
In 2020 you will gain an unrivaled learning experience, across 4 packed days with 4 parallel tracks, including a new track on protein engineering and more on clinical, regulatory and manufacturing challenges.
As Europe’s largest gathering of ADC stakeholders, seize the opportunity to network with 320 drug developers from 160 active ADC organisations as they strive to develop the next generation of clinically impactful ADCs.
For the world-class speaker faculty and full agenda, visit www.worldadc-europe.com
Society members save 10% on the registration fee! Contact us at email@example.com for the code.
Antibody Society Members Save 15% When You Register Here by February 28, 2020!
Learn how to establish optimal cell lines for your antibodies by attending the upcoming Cell Line Development & Engineering US meeting, held March 9-12, 2020 in Santa Clara, California as part of the BioProcess International US West meeting. Learn how to improve product quality, reduce timelines and increase titers by hearing from the brightest minds in cell line development:
A Multi-Omics Platform to Guide Rational Process Development for Recombinant Protein Expression
Hima Yalamanchili, Postdoctoral Fellow at Biogen
Improvement of therapeutic protein production and quality: Coping with ER stress
Tae Kwang Ha, Specialist at Novo Nordisk Foundation Center for Biosustainability, DTU
Establishment of Efficient Platforms for The Generation of Cell Lines Expressing Bispecific Proteins with Desired Quality Attributes
Jie Zhu, Ph.D., Associate Director, Cell Culture and Fermentation Sciences, BioPharmaceuticals at AstraZeneca
Efforts To Achieve Therapeutic Protein Production with Improved Speed, Productivity, and Product Quality while Significantly Reducing Costs
Amy Shen, Technical Development Principal Scientist and Group Leader at Genentech Inc.
Register online by February 28 to save 15% off the current rates – Contact us at firstname.lastname@example.org for the code.
Immunotherapy for Infectious Diseases Conference
March 29 – April 1, 2020, Stresa, Lake Maggiore, Italy
Save the date for the Immunotherapy for Infectious Diseases conference, which brings together academia, small biotech and big pharma and regulatory bodies invested in the discovery of novel therapeutic strategies.
For more information, click here.
Cell Engager Summit
March 30 – April 1, 2020, Boston, MA
The Cell Engager Summit is returning to Boston (March 30 – April 1) for its 2nd year. In a rapidly evolving field, the most pressing challenges must be overcome for these therapeutics to achieve their full clinical potential.
By working closely with industry leaders from Amgen, Pfizer, Regeneron, Harpoon Therapeutics, TeneoBio and more, this meeting aims to identify the most critical hurdles that must be overcome to progress cell engager therapeutics to market.
Here are some of the 2020 highlights:
- Amphivena have relieved immune suppression through selective targeting enabling a more efficacious molecule
- TeneoBio and Xencor are optimizing therapeutic index to ensure patient safety is at the forefront
- Amgen are developing robust preclinical efficacy and safety assessments to allow you to bridge the translational gap to the clinic
- Pfizer are researching into the next generation of cell engagers, allowing you to understand protein engineering and mechanisms of action to improve efficacy
- Attend this meeting to benchmark your progress and engage directly with the organizations at the cutting edge of this rapidly evolving field.
Society members save 10% on the registration fee! Contact us at email@example.com for the code.
PEGS: The Essential Protein Engineering and Cell Therapy Summit
May 4-8, 2020, Boston
Make plans today to join more than 2,800 world-renowned experts, visionaries, and influencers from top pharma, biotech, academic, and government institutions in Boston May 4-8 at PEGS: The Essential Protein Engineering & Cell Therapy Summit to hear inspiring thought leaders, attend in-depth training, tutorials and roundtable discussions, and to gain insights and knowledge on how the latest developments in biotherapeutics will impact and transform current research.
To view the speaker lineup and agenda, visit PEGSummit.com
The Antibody Society members save 20% on the registration fee! Contact us at firstname.lastname@example.org for the code.
Antibody Engineering & Therapeutics Europe
June 9-11, 2020, Amsterdam, The Netherlands
Join us for The Antibody Society’s European meeting for antibody and protein therapeutic science, technology and networking!
Sessions are organized and moderated by Society members. Session details will be posted on the meeting website soon.
See us at Booth #28 to get your free Society T shirt!
Society members save 15% on the registration fee! Contact us at email@example.com for the discount code.
Antibody Engineering & Therapeutics Europe Student/Postdoc Poster Competition.
To recognize the research activities of promising student/postdoc attendees of the Antibody Engineering & Therapeutics conference, The Antibody Society is sponsoring a student/postdoc poster competition. Two student/postdoc winners will be selected to receive:
1. Complimentary registration to attend the conference and pre-conference sessions;
2. An opportunity to give a short oral presentation of their work in a conference session
3. Support for travel expenses (up to $400 for domestic or $800 for international flights, 3 nights at a hotel priced up to $250+taxes/night, ground transportation).
In order to be considered for this poster competition, you must be a student or postdoc member of The Antibody Society. If you are not already a member, you may register here for a free student or postdoc membership. Informa Connect is managing the poster submission process. You must check the box on the poster submission form indicating that you want your abstract to be considered for the poster competition.
Deadline for submission: April 24, 2020
Winners will be notified by May 1, 2020
8th Antibody Industrial Symposium AIS2020
June 22-23, 2020, Montpellier, France
The 8th Antibody Industrial Symposium AIS2020 jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Immunotherapy Industrial sector, will be held the 22nd and 23rd of June 2020 in Montpellier. This year’s edition will focus on a major theme chosen by the Scientific Advisory Board:
“Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases”.
The meeting includes keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies. Moreover, the program will allow opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.
Register early to secure the best rates! Early Bird Registration is available until March 31, 2020.
Society members save 20% on the registration fee! Contact us at firstname.lastname@example.org for the discount code.
Call for abstracts to the #8AIS2020 Congress: Deadline March 27, 2020
Submit your abstract to give a 10 min talk at the Pitch session in the #8AIS2020 Congress, or
Submit your abstract to present your work at the Poster session in the #8AIS2020 Congress.
For more information, visit https://aiscongress.com/
Save the date for AIRR Community Meeting V “Exploring New Frontiers”
La Jolla, CA, December 8-12, 2020.
Meetings and presentations will take place at Scripps Research and the Hilton La Jolla Torrey Pines.
For details, see the AIRR C Meeting V Program.
Antibody Engineering & Therapeutics USA
SAVE THE DATE!
December 13-17, 2020
Marriott Marquis San Diego
San Diego, California